William Blair analyst Matthew Pfau initiates coverage on NAPCO Security Techs (NASDAQ:NSSC) with a Outperform rating.
LumiraDx Gets FDA Emergency Use Authorization Amendment For Its LumiraDx SARS-CoV-2 RNA Star Complete Test Kit To Extend The Shelf Life To 12 Months
https://www.fda.gov/media/165719/download